News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pfizer is far behind weight loss drug race despite pill trial, says Mizuho’s Jared HolzPfizer is far behind weight loss drug race despite pill trial, says Mizuho’s Jared Holz
News

Pfizer is far behind weight loss drug race despite pill trial, says Mizuho’s Jared Holz

July 11, 2024
Steve Ricchiuto on Bloomberg Surveillance (Starts at 2:10:20)Steve Ricchiuto on Bloomberg Surveillance (Starts at 2:10:20)
News

Steve Ricchiuto on Bloomberg Surveillance (Starts at 2:10:20)

July 1, 2024
Dominic Konstam on Bloomberg Surveillance (Starts at 1:17)Dominic Konstam on Bloomberg Surveillance (Starts at 1:17)
News

Dominic Konstam on Bloomberg Surveillance (Starts at 1:17)

June 26, 2024
What the yen's latest tumble means for japanWhat the yen's latest tumble means for japan
News

What the yen's latest tumble means for japan

June 26, 2024
Mizuho's Katz says Greenhill deal widens path to growthMizuho's Katz says Greenhill deal widens path to growth
News

Mizuho's Katz says Greenhill deal widens path to growth

June 25, 2024
Mizuho Americas recognized as founding corporate and philanthropic partner by Genesys Works NYCMizuho Americas recognized as founding corporate and philanthropic partner by Genesys Works NYC
Press Release

Mizuho Americas recognized as founding corporate and philanthropic partner by Genesys Works NYC

June 20, 2024
Mizuho Americas hires Steven Valiquette as Managing Director and Senior Equity Research Analyst to cover Health Care Technology & DistributionMizuho Americas hires Steven Valiquette as Managing Director and Senior Equity Research Analyst to cover Health Care Technology & Distribution
Press Release

Mizuho Americas hires Steven Valiquette as Managing Director and Senior Equity Research Analyst to cover Health Care Technology & Distribution

June 11, 2024
David Bellinger named Business Insider rising star of equity researchDavid Bellinger named Business Insider rising star of equity research
News

David Bellinger named Business Insider rising star of equity research

June 6, 2024
Structure Therapeutics is a ‘no-brainer takeout’ target, says Mizuho’s Jared HolzStructure Therapeutics is a ‘no-brainer takeout’ target, says Mizuho’s Jared Holz
News

Structure Therapeutics is a ‘no-brainer takeout’ target, says Mizuho’s Jared Holz

June 3, 2024
back-to-top-blue